Estimation of Radiotherapy Modalities for Patients With Stage I-Ii Nasal Natural Killer T-Cell Lymphoma

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s201514
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Chemotherapy Combined With High-Dose Extended-Field Radiotherapy for Stage I Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Nasal Natural Killer/T Cell Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

A Case of Primary Gastric Natural Killer/T-Cell Lymphoma, Nasal Type

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2007English

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Involving Skin Masquerading as Eczema

Annals of Dermatology
Dermatology
2016English

Novel Targets for Natural Killer/T-Cell Lymphoma Immunotherapy

Immunotherapy
OncologyAllergyImmunology
2016English

Treatment Outcome of Radiotherapy Alone Versus Radiochemotherapy in IE/IIE Extranodal Nasal-Type Natural Killer/T Cell Lymphoma: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Whole-Genome Sequencing Reveals Immunotherapeutic Options for Natural-Killer/T Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Clinical Characteristics and Treatment of 69 Patients With Extranodal Natural Killer T-Cell Lymphoma

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Impact of Dexamethasone, Etoposide, Ifosfamide and Carboplatin as Concurrent Chemoradiotherapy Agents for Nasal Natural Killer/T-Cell Lymphoma

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy